Disease | Source | Batch | Tags | External Links |
---|---|---|---|---|
melanoma | Nikolaev et al., 2012, Nat. Genet. | My Cancer Genome (View variants) | pathogeniclikely pathogenic | My Cancer Genome |
melanoma | Shi et al., 2012, Cancer Discov | My Cancer Genome (View variants) | pathogeniclikely pathogenic | My Cancer Genome |
skin melanoma | Chang et al., 2016, Nat. Biotechnol. | Pan-cancer recurrent hotspots (View variants) | likely pathogenic | |
uterine corpus endometrial carcinoma | Chang et al., 2016, Nat. Biotechnol. | Pan-cancer recurrent hotspots (View variants) | likely pathogenic | |
colorectal cancer | Chang et al., 2016, Nat. Biotechnol. | Pan-cancer recurrent hotspots (View variants) | likely pathogenic | |
urinary bladder urothelial carcinoma | Chang et al., 2016, Nat. Biotechnol. | Pan-cancer recurrent hotspots (View variants) | likely pathogenic | |
melanoma | Emery et al., 2009, Proc. Natl. Acad. Sci. U.S.A. | CIViC Knowledgebase (View variants) | CIViC |
Therapeutic Context | Pathway | Effect | Association | Status | Evidence | Source |
---|---|---|---|---|---|---|
BRAF inhibitors in BRAF mutant tumor | activation | gain-of-function | case report | emerging | 22588879 |
DoCM by The McDonnell Genome Institute at Washington University School of Medicine is licensed under a Creative Commons Attribution 4.0 International License. Questions? Comments? Concerns? You can contact us here.